AEMD · Aethlon Medical Inc

-

Please sign in to comment on AEMD

1 Comment

Admin

4 years, 1 month ago

Aethlon Medical, Inc is currently in a long term uptrend where the price is trading 93.6% above its 200 day moving average.

From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 26.3.

Aethlon Medical, Inc's total revenue rose by 51.1% to $625K since the same quarter in the previous year.

Its net income has dropped by 198.1% to $-2M since the same quarter in the previous year.

Finally, its free cash flow fell by 73.5% to $-2M since the same quarter in the previous year.

Based on the above factors, Aethlon Medical, Inc gets an overall score of 3/5.

Exchange	NASDAQ
CurrencyCode	USD
Industry	Medical Devices
ISIN	US00808Y3071
Sector	Healthcare

Market Cap	6M
PE Ratio	None
Target Price	3.875
Beta	1.72
Dividend Yield	None

ABOUT

Aethlon Medical Inc

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

AEMD · Aethlon Medical Inc

-

Aethlon Medical Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Aethlon Medical Inc using a moving average strategy